Clinical Trials Directory

Trials / Terminated

TerminatedNCT05528757

Limb-Girdle Video Assessment

Limb-Girdle Video Assessment Concept Elicitation and Feasibility Study

Status
Terminated
Phase
Study type
Observational
Enrollment
45 (actual)
Sponsor
The Emmes Company, LLC · Industry
Sex
All
Age
14 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to develop a new remote-based video assessment outcome measure for Limb-Girdle Muscular Dystrophy (LGMD) trials. The overall objectives for this study are: 1. Identify domains and tasks meaningful to participants with a Limb-Girdle Muscular Dystrophy (LGMD) for development of the LGVA, including considerations for subtype heterogeneity and functional subgroup branching; 2. Determine the feasibility and reliability of the LGVA with test-retest of the LGVA Video Capture Manual; 3. Assess and refine the LGVA Video Capture Manual to ensure standardization and incorporate feedback from participants; 4. Collect source material videos using the LGVA Video Capture Manual to support the development of scorecards for the LGVA.

Detailed description

The purpose of this study is to gain insight from people living with an LGMD and gather source material videos to develop and test Limb-Girdle Video Assessment (LGVA), a new outcome measure designed to assess changes in functional abilities of participants in LGMDs clinical trials. The LGVA is being designed as a remote video capture to assess nuanced changes in compensatory movement patterns over time. This study involves two stages. In the concept elicitation stage, the tasks for the LGVA Video Capture Manual will be finalized based on feedback from participants living with an LGMD 2A, 2B, or 2I in various stages of disease progression. After finalizing the LGVA Video Capture Manual, source material videos will be collected to evaluate the feasibility and appropriateness of the LGVA tasks, standardize capture procedures, and inform the development of scorecards for the LGVA.

Conditions

Timeline

Start date
2022-06-20
Primary completion
2022-11-02
Completion
2022-11-02
First posted
2022-09-06
Last updated
2023-12-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05528757. Inclusion in this directory is not an endorsement.